Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Montrose Capital Partners
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Montrose Capital Partners has funded numerous biotech/healthcare companies at various clinical stages. Portfolio highlights include: Dyadic International: Biopharmaceutical gene expression; C1 platform; development/manufacturing of vaccines, mAbs, proteins; pipeline includes biosimilars and vaccines. Lomond Therapeutics: Small molecule inhibitors for hematologic cancers; pre-clinical to early clinical stage; AI-enabled platform. Prolor Biotech (acquired): Long-acting human growth hormone, hemophilia factors, diabetes/obesity peptides; Phase II and acquired by OPKO Health. Exicure: Synthetic oligonucleotide drugs (SNA technology); programs in inflammation, genetic disorders, oncology; clinical stage. InVivo Therapeutics: Biomaterials and biotechnology for spinal cord injury; clinical-stage.
- Therapeutic areas
- ImmunologyEndocrinologyNeurologyRare DiseasesOncology
- Modalities
- Small moleculeMonoclonal antibodyFab antibody fragmentFc-Fusion proteinBiosimilar/BiobetterTherapeutic proteinVirus-like particlePeptideSynthetic oligonucleotide
- Industry
- Investors
02
Partnerships
Co-invests with OrbiMed, Xeraya Capital, Kearny Venture Partners, CRG L.P.Lomond Therapeutics: Co-founded with OrbiMed, Torrey Pines Investment
Beyond the preview
Go deeper on Montrose Capital Partners.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Montrose Capital Partners.